ArticleScientific reports2017

Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy.

Wenda Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.